NM_002386.4:c.456C>A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 4P and 4B. PVS1_StrongBS2
The NM_002386.4(MC1R):c.456C>A(p.Tyr152*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00054 in 1,606,408 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_002386.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MC1R | ENST00000555147.2 | c.456C>A | p.Tyr152* | stop_gained | Exon 1 of 1 | 6 | NM_002386.4 | ENSP00000451605.1 | ||
ENSG00000198211 | ENST00000556922.1 | c.456C>A | p.Tyr152* | stop_gained | Exon 1 of 5 | 2 | ENSP00000451560.1 |
Frequencies
GnomAD3 genomes AF: 0.000545 AC: 83AN: 152264Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000840 AC: 204AN: 242812Hom.: 2 AF XY: 0.000870 AC XY: 115AN XY: 132240
GnomAD4 exome AF: 0.000539 AC: 784AN: 1454026Hom.: 5 Cov.: 34 AF XY: 0.000547 AC XY: 396AN XY: 723708
GnomAD4 genome AF: 0.000545 AC: 83AN: 152382Hom.: 0 Cov.: 33 AF XY: 0.000564 AC XY: 42AN XY: 74512
ClinVar
Submissions by phenotype
Melanoma, cutaneous malignant, susceptibility to, 5 Uncertain:1Benign:1
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
This sequence change creates a premature translational stop signal (p.Tyr152*) in the MC1R gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 166 amino acid(s) of the MC1R protein. This variant is present in population databases (rs201326893, gnomAD 1.0%), and has an allele count higher than expected for a pathogenic variant. This variant has been reported in individuals affected with melanoma (PMID: 23522749, 15998953, 19269164, 17496785, 31382929), as well as unaffected individuals (PMID: 15221796, 19585506, 19269164). lt has been observed more frequently in individuals with red hair and pale skin phenotypes (PMID: 11933208, 17316231). Pigmentation of the hair and skin is correlated with ultraviolet sensitivity and skin cancer. Other loss-of-function missense variants in MC1R have been correlated with lighter skin pigmentation (PMID: 11030758) and possibly increased melanoma risk, although no definitive disease association has been concluded (PMID: 18366057, 21128237). ClinVar contains an entry for this variant (Variation ID: 265230). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Tyrosinase-positive oculocutaneous albinism;C1849452:SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 2;C2751295:Melanoma, cutaneous malignant, susceptibility to, 5;C2751296:Increased analgesia from kappa-opioid receptor agonist, female-specific Uncertain:1
- -
not provided Uncertain:1
Nonsense variant predicted to result in protein truncation in a gene or region of a gene for which loss of function is not a well-established mechanism of disease; This variant is associated with the following publications: (PMID: 11933208, 34662886, 16567973, 15998953, 30531825, 31382929, 26689913, 34426522, 23711066, 17496785) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at